Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
NearWave
AddedMar 22, 2024
UpdatedJul 3, 2026
NearWave

NearWave

Seed

NearWave: Handheld device for precise breast cancer therapy selection, enhancing point-of-care diagnostics.

HQ
South Bend, IN, US
Founded
2020
Accelerator
Y Combinator logoY CombinatorW22
Overview
Compare
Fundraising
Employees
Website

NearWave develops advanced medical imaging technology, focusing on a handheld device that utilizes frequency domain near-infrared spectroscopy (fdNIRS) for breast cancer diagnostics. Their NearWave Scanner is designed to assess vital biomarkers, including tissue oxygen saturation and hemoglobin concentrations, non-invasively and without ionizing radiation. This technology aims to assist physicians in selecting optimal therapies for breast cancer patients, potentially reducing unsuccessful treatments and associated side effects.

The company's innovative approach to point-of-care diagnostics represents a significant advancement in medical imaging. NearWave's scanner is notable for its compact size, speed, and ease of use, positioning it as a breakthrough in fdNIRS technology. While currently used for research purposes, the NearWave Scanner shows promise in enhancing breast cancer treatment decisions and improving patient outcomes.

NearWave - Similar Companies

Waved Medical logo

Waved Medical

Spectrawave logo

Spectrawave

spectrawave.com

WaveDyn Vision logo

WaveDyn Vision

Near Infrared Imaging logo

Near Infrared Imaging

Nirmidas Biotech logo

Nirmidas Biotech

Bired Imaging logo

Bired Imaging

biredimaging.com

WaveFront Dynamics logo

WaveFront Dynamics

Caia logo

Caia

Nano Mobile Healthcare logo

Nano Mobile Healthcare

Naveris logo

Naveris

naveris.com

iSono Health logo

iSono Health

isonohealth.com

Neuright logo

Neuright

neurightlabs.com

NeuroFieldz logo

NeuroFieldz

neurofieldz.com

Scanbase logo

Scanbase

scanbase.com

Neodocs logo

Neodocs

neodocs.in

NearWave - Quick Facts

Who are NearWave's competitors?

Companies similar to NearWave include Waved Medical, Spectrawave, WaveDyn Vision and Near Infrared Imaging.

When was NearWave founded?

NearWave was founded in 2020.

Where is NearWave's headquarters located?

NearWave's headquarters is located in South Bend, IN, US.

When was NearWave's last funding round?

NearWave's most recent funding round was for $500k (USD) in June 2022.

How much has NearWave raised to-date?

As of Jun 15, 2022, NearWave has raised a total of $500k (USD).

How many employees does NearWave have?

NearWave has 8 employees as of Feb 24, 2024.

NearWave - Classification

Industry
  • Hardware
Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Diagnostics
  • Medical Imaging
Tags
  • Healthcare
  • Healthtech
  • Medical